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Abstract
Background: To investigate the factor structure, dimensionality and construct validity of the (5-
item) PRAFAB questionnaire score in women with stress urinary incontinence (stress UI).
Methods: A cross validation study design was used in a cohort of 279 patients who were randomly
divided into Sample A or B. Sample A was used for preliminary exploratory factor analyses with
promax rotation. Sample B provided an independent sample for confirming the premeditated and
proposed factor structure and item retention. Internal consistency, item-total and subscale
correlations were determined to assess the dimensionality. Construct validity was assessed by
comparing factor-based scale means by clinical characteristics based on known relationships.
Results: Factor analyses resulted in a two-factor structure or subscales: items related to 'leakage
severity' (protection, amount and frequency) and items related to its 'perceived symptom impact'
or consequences of stress UI on the patient's life (adjustment and body (or self) image). The
patterns of the factor loadings were fairly identical for both study samples. The two constructed
subscales demonstrated adequate internal consistency with Cronbach's alphas in a range of 0.78
and 0.84 respectively. Scale scores differed by clinical characteristics according to the expectations
and supported the construct validity of the scales.
Conclusion:  The findings suggest a two-factorial structure of the PRAFAB questionnaire.
Furthermore the results confirmed the internal consistency and construct validity as demonstrated
in our previous study. The best description of the factorial structure of the PRAFAB questionnaire
was given by a two-factor solution, measuring the stress UI leakage severity items and the
perceived symptom impact items. Future research will be necessary to replicate these findings in
different settings, type of UI and non-white women and men.
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Background
Urinary incontinence (UI) is a common condition that
affects approximately five to seven percent of adults in the
Netherlands [1,2] increasing in the elderly to nine percent
for men and 29% for women [3]. However, these esti-
mates of prevalence are strongly influenced by the defini-
tion of UI. The most prevalent type of female UI is stress
UI and it has been suggested that about 50% of patients
have stress UI, 16% urgency UI and 34% symptoms of
both types (mixed UI) [1,2]. UI is consistently associated
with embarrassment, distress and anxiety, which may neg-
atively affect social participation, intimate relationships
and self-esteem and may have severe repercussions on the
patient's quality of life (QoL) [4-6]. The relationship
between UI leakage severity and perceived symptom
impact is highly variable [5].
The importance of measuring the impact of UI severity on
quality of life in patients is not only essential in research
to assess the effectiveness of clinical interventions but also
important in the assessment of outcomes in daily clinical
practice. However, quality of life questionnaires are time
consuming and so limited in their usage in daily clinical
practice. Brief, valid and responsive outcome measures
that combine UI leakage symptoms and the subjective
impact on a patient's life are needed in clinical practice
[7]. The PRAFAB questionnaire is potentially such an out-
come measure [8] and is widely used in the Netherlands
by physiotherapists [9], researchers [3,10,11] and to a
lesser extent by general practitioners, urologists and
gynaecologists. The PRAFAB questionnaire combines rele-
vant objective and subjective aspects of UI severity, is
quick and easy to administer and has the additional value
of including the subjective aspects of UI [8,9].
Recently, the PRAFAB questionnaire has been shown to be
a reliable and valid outcome measure with excellent
responsiveness to clinical changes in a longitudinal study
of women with stress or urgency UI [7]. In our previous
psychometric study we were not able to demonstrate a
two-factor solution as was theoretically expected: the
more objective UI 'leakage severity' items and the more
subjectively 'perceived symptom impact' items. However,
the factor structure had never formally been tested before
[7]. The most likely explanation is that our study was
underpowered for appropriate factor analyses but, on the
other hand, the PRAFAB questionnaire may also have
only one strong underlying factor. Some authors recom-
mend that adequate solutions can be obtained with five to
ten participants per variable as long as there are at least
100 patients in the sample [12-15]. The data in our larger
prospective cohort study allowed us to more appropri-
ately investigate the multi dimensionality and expected
two-factor structure of the PRAFAB questionnaire score in
a large cohort group of women with stress UI (N = 279).
Summary indices of the two subscales 'leakage severity'
and its 'perceived symptom impact' may be used as sepa-
rate outcomes in future research, instead of the total PRA-
FAB questionnaire score, thereby emphasizing that the
questionnaire contains two different concepts.
The aim of this study was twofold. First, to investigate the
factor structure and dimensionality of the (5-item) PRA-
FAB questionnaire score and secondly to replicate the con-
struct validity of the PRAFAB questionnaire based on our
previous findings.
Methods
Study population
Data were derived from a prognostic cohort study of 279
mainly Caucasian women (96%) with a primary or recur-
rent episode of stress UI referred for physiotherapy treat-
ment by GPs or urogynaecologists. Stress UI was defined
as involuntary leakage during effort, exertion or sneezing
and/or coughing [16]. The 34 participating physiothera-
pists are experienced in women's health and work in dif-
ferent private practices in the Netherlands. The cohort of
patients treated by these physiotherapists was followed
from their initial visit up to 12 weeks (clinical course) or
end of treatment.
The data consist of women who were at least 18 years of
age who had had stress UI episodes for six months or
more. All patients referred with a diagnosis of stress or
dominant stress UI were included. In cases of uncertainty,
patients received a self-evaluation 4-day diary at baseline,
including the weekend, to classify whether they had either
stress or predominant stress UI [17,18]. Exclusion criteria
were urgency or dominant urgency UI, current pregnancy
or being within 6 months after delivery, post-operative
status within 6 months, patients who exhibit signs of
active urinary tract infection, serious neurological pathol-
ogy, diabetic neuropathy, congenital urological disorders,
cognitive impairments or bladder cancer, and those who
were unable to read and understand Dutch.
The characteristics of the study population are summa-
rized in Table 1. There were no significant baseline differ-
ences between the samples with the exception of the
number of patients with previous stress UI related surgery
(p = 0.02). There were no missing data on baseline PRA-
FAB questionnaires. The medical ethics committees of the
Deventer Ziekenhuizen approved the informed consent
procedure and protocol. Only those participants who
signed an informed consent form were included in this
study.
PRAFAB questionnaire
The PRAFAB questionnaire combines important objective
and subjective aspects of UI severity: Protection (the use ofBMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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pads), Amount of urine loss, Frequency of UI, Adjustment
of behaviour due to the symptoms, and Body (or self)
image as a result of the stress UI symptoms (Table 2) [8].
Each item can be awarded up to 4 points (1–4) with a
total PRAFAB questionnaire score of 20 points (min-max
= 5–20; range = 16 points). The author(s) reported high
crude agreement between assessors on total scores and
'severe' urine loss (score ≥ 14 points) compared with the
Incotest [8]. The PRAFAB questionnaire discriminates
between less or more than 2 gram urine loss per hour with
a score ≥ 14 points. The positive predictive value of 'severe'
urine loss was 83% for urine loss (> 2 gram/hour on a
pad-test with standardized bladder volume). The negative
predictive value was 61%. The PRAFAB questionnaire
score is quick and easy to administer compared to a pad-
test with standardized bladder volume or QoL question-
naires, and has the additional value of including the per-
ceived symptom impact of UI [8,9]. In our previous
psychometric study the PRAFAB questionnaire demon-
strated high internal consistency (alpha = 0.82), test-retest
reliability (ICCagreement = 0.96) and responsiveness on the
total score with a minimally important change (MIC) of -
3.0 and -5.0 points as a rule-of-thumb for patients classi-
fied as non-severe or severe [7]. The PRAFAB question-
naire was administered at baseline, 12 weeks of follow-up
and at the end of treatment.
Factor analyses
A cross validation study design was used in which the total
cohort of 279 patients was randomly divided into two
samples, stratified for stress UI severity (29% of the
patients scored ≥ 14 points on the total PRAFAB question-
naire score), in preparation for the exploratory and con-
firmatory factor analyses. In Sample A, comprising 140
women, exploratory factor analyses were applied to
extract the number of meaningful factors or items. The
factor structure of the 5-item PRAFAB questionnaire was
investigated by principal component analysis (PCA).
Sample B provided an independent sample for confirma-
tory factor analysis (CFA) to test whether the data fit the
premeditated factor solution as obtained in Sample A [12-
15,19]. We used two different methods for CFA: firstly, a
'simple structure' PCA as a method of replicating the
results ('simple structure' analysis) [13] and secondly, the
maximum likelihood analysis [13-15,19]. A 'simple struc-
ture' replication analysis was carried out accordingly on
the analysis in Sample A, based on the grounds that if
'simple structure' replication in Sample B reflects the same
underlying dimensions it will be the most parsimonious
explanation of the data. Moreover, if the replication anal-
ysis in Sample B demonstrates a different structure com-
pared to those in Sample A the premeditated factor
solution will be refuted [13].
Table 1: Baseline demographic and clinical characteristics: % (no.) unless otherwise stated
Sample A (N = 140) Sample B (N = 139) P-value
%n%n
Urogynaecologist referral for physiotherapy 45.7 64 46.7 65 0.94
Type UI (stress UI) 87.9 123 84.2 117 0.38
Age (year) (mean; SD) 46.8(8.2) 48.4 (8.2) 0.11
<45 36.4 51 31.7 44
45–54 45.7 64 45.3 63 0.15
>54 17.9 25 23.0 32
Educational level (low) 25.0 35 25.0 35 0.96
Parity (mean number; SD) 1.74 (1.3) 1.58 (1.4) 0.31
03 4 . 3 4 8 2 8 . 6 3 6
1–2 43.6 61 53.6 71 0.27
≥ 32 2 . 1 3 1 1 7 . 8 3 2
Onset UI symptoms (year) (mean; SD) 5.4 (7.0) 6.7 (7.9) 0.17
<1 32.1 45 36.0 50
1–5 35.7 50 37.4 52 0.33
>5 32.1 45 26.6 37
Menopausal status (pre [vs. post]) 61.4 86 64.0 89 0.66
Physical health (poor) 23.6 33 17.3 24 0.19
Body Mass Index (> 30 kg/m2) 9.4 13 9.3 13 0.98
Previous UI surgery (> 6 months ago) a 20.1 28 32.1 45 0.02
Co morbidity (yes) b 24.5 34 27.9 39 0.52
Low back pain (>12 weeks) c 12.9 18 10.1 14 0.44
a Surgical procedures were related to women's stress urinary incontinence.
b Co morbidity included (n Sample A/B): COPD (19/12), cardiovascular problems (11/14), and diabetes type-2 (6/9).
c Low back pain (including those with leg pain below the knee (n Sample A/B (6/5))BMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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Factors that emerged from the 'simple structure' PCA were
rotated using promax (oblique) rotation to facilitate inter-
pretation [12-15,19]. Item loadings ≥ 0.40 on one factor
and cross loadings ≤ 0.30 on any other factor were
accepted [12-15,19]. Factor loadings after oblique rota-
tion in the maximum likelihood analysis may fall outside
the range of -1.0 to +1.0. The final models were evaluated
using the following fit indices: (1) chi-square goodness-
of-fit test, which evaluates the significance of unexplained
covariances (or covariances among measured variables
that are not accounted for by the model), in which the p-
values should not be significant and (2) chi-square/df
ratio in which values should be < 2.0 [13-15,19].
Determination of the number of factors to be retained in
the final solution was based on the following indices.
Firstly, the Scree test was examined to identify the number
of factors and to interpret the factor solutions [13-15,19].
Using the Scree plot we looked for a break between factors
with relatively large eigenvalues (>1.0) and those with
smaller eigenvalues. Factors that appeared before the hor-
izontal break were assumed to be meaningful. Secondly,
we examined the magnitude of the eigenvalues, the per-
centage of explained variance and factor loadings after
PCA with promax (oblique) rotation. Final conclusions
were based on the results of the CFA because of the more
powerful test properties of factorial validity compared to
the exploratory approaches [13-15,19,20].
Internal consistency
Data from Sample B were used to evaluate construct valid-
ity and compared to Sample A. Internal consistency was
assessed using Cronbach's alpha, Spearman inter-item
and item-total correlations [21,22] of the different sub-
scales or otherwise the total scale. All the items should
assess different aspects of the same construct. Adequate
alpha values should be higher than 0.70 and values higher
than 0.80 are considered as excellent [14,23]. However,
alpha values higher than 0.90 of individual items may
indicate redundancy [24]. Adequate levels of item-total
Table 2: The PRAFAB questionnaire score*
Protection
1. I never use protection for urine loss
2. I sometimes use protection, or I have to change my underwear because of urine loss
3. I normally use protection, or change my underwear several times a day because of urine loss
4. I always have to use protection because of urinary incontinence
Amount
1. The amount of urine loss is just a drop or less
2. Sometimes I loose a trickle
3. The loss of urine is so much that it wets noticeably my protection or clothes
4. The loss of urine is so much that my protection is soaked or leaks
Frequency
Involuntary loss of urine occurs:
1. Once a week or less
2. More than once but less than three times a week
3. More than three times a week, but not every day
4. Every day
Adjustment
Implications of urine loss:
1. I am not hampered in my daily activities
2. I have stopped some activities, such as some sports and physically demanding activities
3. I have stopped most physical activities that caused involuntary loss of urine
4. I almost never go out
Body (or self) image
1. I am not bothered by my urine loss
2. I think urine loss is annoying and troublesome, but I am not greatly bothered by it
3. Urine loss makes me feel dirty
4. I am disgusted by myself because of my urinary incontinence
Total score:
* The PRAFAB questionnaire is validated in Dutch. Psychometric testing of the English version is not performed. Nevertheless this questionnaire is 
provided in English to give the readers insight in the items and scoring system (min-max = 5–20 points; range 16 points)BMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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(item-to-scale) coefficients are scores between 0.3 and 0.9
[24]. Items with an item corrected-total correlation of less
than 0.20 are likely to be assessing a different construct
from the other items of that measure [24,25]. Inter-factor
correlations were calculated to give further insight into the
interpretability of the constructed factors as separate
scales. Correlations of less than 0.70 support the multidi-
mensionality of the questionnaire.
Construct validity
Data from the total sample (N = 279) were used to evalu-
ate construct validity. Construct validity examines the
scale scores based on known groups or relates to other
measures based on theoretically derived hypotheses con-
cerning the concept being measured. The ability of the
PRAFAB questionnaire to discriminate in UI severity
between individuals was explored on baseline characteris-
tics as was demonstrated in our previous study [7] and for
example by Fultz et al. [4], Gasquet et al. [5] and Melville
et al. [6]. Higher total PRAFAB scores, specifically on the
urinary leakage items (amount and frequency) were
expected (I) in patients referred by urogynaecologists
compared to those referred by GPs [4,7], (II) in patients
with failed stress UI surgery [6,7], (III) in patients with co-
morbid conditions compared to those who have not [6,7],
(IV) in patients with chronic low back pain (> 12 weeks)
[26], (V) in patients with poor (self-rated) physical health
[4,7] and (VI) in patients with a higher Body Mass Index
(BMI > 30 kg/m2) [6,7]. Furthermore we expected lower
total and subscale scores in patients with a higher educa-
tion (VII) [4,7]. The results on potential factors (sub-
scales) will be explored.
Statistical analyses
First, we tested whether the data showed an approxi-
mately normal distribution (values of skewness and kur-
tosis between +1 and -1). All statistical tests were two-
tailed and conducted with a type-1 error set at a Pα < 0.05.
Descriptive statistics were presented for demographic and
clinical characteristics and the PRAFAB questionnaire.
Summaries of categorical variables included frequency
and the percentage of patients within each category. Sta-
tistical analysis comparing patient characteristics or
results between groups was performed using the Student's
t-test (or one-way ANOVA), or in skewed data the non-
parametric chi-square or Kruskall-Wallis test where appro-
priate. Continuous variables were summarized with mean
and standardized deviation (SD) unless otherwise noted.
All analyses were performed with SPSS (version 13.0,
2005).
Results
Distributional characteristics of the 5-item PRAFAB 
questionnaire
The PRAFAB questionnaire item and total means (SD) for
each sample are presented in Table 3. There were no sig-
nificant differences between Sample A and Sample B.
Most items were normally distributed except the item
adjustment in both Samples A and B (statistical indices of
skewness and kurtosis are larger than + 1 or -1).
Factor analyses
Exploratory factor analyses in Sample A
The Scree plot applied to data from Sample A showed a
distinct break before factor 3, suggesting a two-factor solu-
tion of the PRAFAB questionnaire that may be adequate to
describe the data (Figure 1). The first two eigenvalues of
those unforced factors before rotation were 2.14 and 1.05.
Note that the percentage of variance will not change fol-
lowing PCA but the eigenvalues will change. The eigenval-
ues for both factors after promax (oblique) rotation was
1.99 and 1.48 respectively. The total explained variance
before rotation of the two factors was 64% of the variabil-
ity of the original 5-item PRAFAB questionnaire. The ini-
tial two-factor solution accounted for 42.8% and 21.2%
of the variance respectively (Table 4). The identified items
with high loadings on the first factor were protection,
amount and frequency (Factor 1: defined as 'leakage
severity') and items with high loadings on the second fac-
tor were adjustment and body (or self) image (Factor 2:
defined as 'perceived symptom impact').
Table 3: Descriptive statistics of baseline PRAFAB questionnaire scores for Sample A and Sample Ba
Study A (N = 140) Study B (N = 139) P-value
Mean (SD) Median Range Mean (SD) Median Range
Protection 2.74 (0.97) 3 1–4 2.83 (0.92) 3 1–4 0.39
Amount 2.37 (0.71) 2 1–4 2.45 (0.68) 2 1–4 0.33
Frequency 2.94 (1.11) 3 1–4 2.97 (1.01) 3 1–4 0.82
Adjustment 1.44 (0.66)b 1 1–3 1.42 (0.64)b 1 1–3 0.89
Body image 2.36 (0.49) 2 2–4 2.35 (0.52) 2 2–4 0.85
Total score 11.85 (2.61) 12 7–18 12.04 (2.53) 12 6–18 0.55
a No significant differences between Sample A and B (Student t-test]; verified by Kruskall-Wallis test for non parametric data).
b Skewed and non normally distributions of itemsBMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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Confirmatory factor analyses in Sample B
In Sample B we evaluated the specified two-factor model
of Sample A using a forced two-factor solution via PCA
followed by promax (oblique) rotation ('simple structure'
replication analysis as a CFA method). The forced two-fac-
tor solution identified the same two-factor structure as
obtained in Sample A with comparable high factor load-
ings, confirming that these two factors may be adequate to
describe the data. The results of the confirmatory analyses
are shown in Table 4. The factor loadings were high, rang-
ing from 0.73 to 0.81 for Factor 1 and 0.78 to 0.84 for Fac-
tor 2, also indicating that all the individual items are
Scree plot of eigenvalues from the 5-item PRAFAB questionnaire of Sample A Figure 1
Scree plot of eigenvalues from the 5-item PRAFAB questionnaire of Sample A.
Table 4: Results of exploratory factor analyses in Sample A followed by confirmatory factor analyses in Sample B with final factor 
loadings of the forced premeditated two-factor model of the PRAFAB questionnaire after promax (oblique) rotation using principal 
component analyses ('simple structure' replication analysis) and maximum likelihood analysis
Exploratory Factor Analysis Confirmatory Factor Analysis
Sample A (N = 140) Sample B (N = 139)
Simple structure Maximum Likelihood d
Factor 1 Factor 2 Factor 1 Factor 2 Factor 1 Factor 2
Protection 0.85 0.06 0.81 0.23 0.71 0.21
Amount 0.83 0.23 0.76 0.14 0.57 0.13
Frequency 0.66 0.40 0.73 0.37 0.58 0.31
Adjustment 0.08 0.79 0.25 0.78 0.28 0.40
Body (or self) image 0.35 0.77 0.24 0.84 0.26 0.93
Eigenvalue before rotation a 2.14 1.05 2.06 1.04 1.25 1.09
Explained variance (%) b 42.8% 21.2% 41.2% 20.8% 25.1% 21.8%
Eigenvalue after rotation a,c 1.99 1.48 1.87 1.53 1.19 1.31
a Factor loadings ≥ 0.40 are in bold.
b Percentage of explained variance per factor before and after oblique rotation is the same in PCA.
c Because factors are correlated the rotation sum-of-squared loadings cannot be interpreted in terms of proportion of variance or added to obtain 
a total variance.
d Chi-square goodness-of-fit test: chi-square 1.314; df = 1; p = 0.25BMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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meaningful to be retained. The first two eigenvalues, as a
result of the forced two-factor solution after promax
(oblique) rotation using PCA, were 2.06 and 1.04. These
factors accounted for 41.2% and 20.8% of the variance
respectively. The first factor represented the three UI leak-
age items and the second factor the perceived symptom
impact of stress UI.
The maximum likelihood analysis confirmed the results
of the 'simple structure' analysis in Sample B although the
factor loadings on the 'perceived symptom impact' sub-
scale were slightly different compared to those of the 'sim-
ple structure' analysis. The factor loadings were
considered high (> 0.40) for Factor 1 (UI leakage items),
ranging from 0.57 to 0.71, and the perceived symptom
impact item 'body (or self) image' (0.93) but borderline
for the perceived impact item 'adjustment' with a factor
loading of 0.40.
It should be noted that the frequency item in both the
exploratory and confirmatory factor analysis had rela-
tively moderate loadings or associations with Factor 2
(ranging from 0.31 to 0.40) but consistently smaller load-
ings in all analyses compared to the frequency items of
Factor 1. In general the results of the maximum likelihood
analysis were consistently lower than the results of the
'simple structure' PCA, except for the item body image
which had a higher factor loading of 0.93. All individual
items are meaningful to be retained although borderline
for the item adjustment. The eigenvalues as a result of the
maximum likelihood analysis after rotation were 1.19 and
1.31. Both factors accounted for 25.1% and 21.8% of the
variance respectively. Because factors are correlated the
rotation sum-of-squared loadings cannot be interpreted
in terms of proportion of variance or added to obtain a
total variance. The maximum likelihood analysis suggests
a good model fit based on the chi-square goodness-of-fit
test in which the p-value was not significant (p = 0.25)
with a chi-square/df ratio of 1.31 i.e. less than the 2.0 cri-
terion.
Internal consistency
Internal consistencies and item-total correlations are
shown in Table 5. In Sample B the Cronbach's alpha coef-
ficient for the PRAFAB questionnaire subscale 'Leakage
severity' was 0.78 with item-total correlations ranging
from 0.67 to 0.85, and Spearman inter-item correlations
ranging from 0.42 to 0.68, indicating that the items were
rather homogenous. The Cronbach's alpha for the sub-
scale 'Perceived symptom impact' was 0.82 with item-
total correlations ranging from 0.74 to 0.84, and a slightly
weaker inter-item correlation of 0.46 compared with the
inter-item correlations of the subscale 'Leakage severity'
(Table 5). These results were quite similar to those of Sam-
ple A. The correlation between both subscales (factors)
was 0.31 in both study samples. The inter-factor correla-
tion of less than 0.70 supports the multidimensionality of
the PRAFAB questionnaire.
Construct validity
As presented in Table 6, six out of the eight hypotheses
confirmed our previous findings for construct validity on
baseline characteristics. Patients referred from urogynae-
cologists (1), having poor self-rated physical health (2),
with a dissatisfying outcome following surgery (> 6
months ago) (3), with co-morbid conditions (4), or
chronic low back pain (including those with leg pain
below the knee) (5) had significant higher total baseline
scores and on the subscale 'leakage severity'. Patients with
a higher education compared to those who had not, had
lower leakage severity and perceived impact scores (6).
Patients with mixed (but dominant) stress UI or a high
BMI (> 30 kg/m2) did not show a difference in the total
PRAFAB questionnaire or 'leakage severity' scores as
hypothesized, but patients with mixed UI experienced a
greater symptom impact from their UI compared to those
who had not, while patients with a higher BMI experi-
enced a lower impact from their UI. The results of the con-
struct validity analyses also demonstrate the variable
Table 5: Internal consistency and item-total correlations of the specified subscales of the PRAFAB questionnaire
Sample A (N = 140) Sample B (N = 139)
Internal consistency (Cronbach's alpha):
Factor 1: leakage severity 0.82 0.78 a
Factor 2: perceived impact 0.84 0.82 a
Inter-factor correlations 0.31b 0.31 b
Item-total correlations (range):
Factor 1: leakage severity 0.67 – 0.83 0.67 – 0.85
Factor 2: perceived impact 0.76 – 0.87 0.74 – 0.84
a Inter-item correlations ranged from 0.42 to 0.68 for Factor 1 and was 0.46 for Factor 2 in Sample B.
b p < 0.01BMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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relationship between urinary leakage severity and per-
ceived symptom impact subscales.
Discussion
The primary aim of this study was to investigate the factor
structure of the PRAFAB questionnaire and dimensional-
ity of potential subscales in a sample of 279 women with
stress UI. The results of our factor analyses demonstrate
the more or less expected two-factorial structure of the
PRAFAB questionnaire. Therefore, it is strongly recom-
mended to use these two subscales as separate outcomes
in future research instead of presenting a total score for the
five individual items of the PRAFAB questionnaire. The
two factors had adequate to good internal consistency
reliability. The inter-subscale correlation was moderate
[13-15,19]. Furthermore, the results confirmed the con-
struct validity as demonstrated in our previous psycho-
metric study [7].
To retain items we decided to accept as relevant only fac-
tor loadings on individual items of at least 0.40 and to
eliminate items from the PRAFAB questionnaire with sub-
stantial loadings (> 0.30) on more than one factor [13,15-
19]. All the individual items fulfilled these criteria to be
retained in the 5-item PRAFAB questionnaire (factor load-
ings ranged from 0.73 to 0.84 on the individual items)
based on the 'simple structure' method but were border-
line acceptable for the item adjustment of Factor 2 with a
factor loading of 0.40 based on the maximum likelihood
analysis (factor loadings ranged from 0.40 to 0.93). The
best description of the factorial structure of the PRAFAB
questionnaire in this sample of women with stress UI was
given by a two-factor solution, measuring stress UI leak-
age severity (protection, amount and frequency) and per-
ceived symptom impact (body (or self) image but
borderline for the item adjustment). The first subscale 'UI
leakage severity' may be considered as the strongest factor,
with the highest explained variance in all confirmatory
factor analyses. Both subscales demonstrated at least ade-
quate internal consistencies (>0.70), inter-item and item-
total correlations. The results of our exploratory and con-
firmatory factor analyses, in both random samples, were
very similar with consistent two-factor structure solutions
that confirmed the hypothesized and proposed subscales
of the PRAFAB questionnaire. As a confirmatory proce-
dure, factor analysis supports the construct validity of the
PRAFAB questionnaire measuring stress UI 'leakage sever-
ity' and 'perceived symptom impact' of stress UI.
Table 6: Mean total PRAFAB questionnaire and subscale scores as determined in the total group
N (%) Total score Leakage severity Perceived impact
1. Referrer
GP 150 (53.8) 11.46 (2.39) 7.69 (1.96) 3.51 (0.65)
Urogynaecologist 129 (46.2) 12.52 (2.67) * 8.72 (2.19) * 4.10 (1.10) *
2. Type of stress UI
Stress UI 240 (0.86) 11.85 (2.52) 8.09 (2.16) 3.69 (0.86)
Mixed UIa 39 (0.14) 12.49 (2.83) 8.60 (1.90) 4.30 (1.11) *
3. Education
Low/middle 209 (74.9) 12.10 (2.54) 8.43 (2.01) 3.86 (0.98)
High 70 (25.1) 11.53 (2.62) 7.43 (1.91) * 3.41 (0.75) #
4. Physical health
Poor 57 (20.4) 12.30 (2.74) # 8.91 (2.03) * 3.70 (0.96)
Moderate-excellent 222 (79.6) 11.85 (2.52) 7.96 (2.10) 3.80 (0.93)
5. Body Mass Index (kg/m2)
< 30 253 (90.7) 11.97 (2.56) 8.16 (2.14) 3.83 (0.93)
≥ 30 26 (9.3) 11.69 (2.65) 8.15 (1.95) 3.34 (0.74) #
6. Failed UI surgery b
No 206 (26.2) 11.67 (2.52) 7.93 (2.06) 3.66 (0.81)
Yes 73 (26.2) 12.71 (2.54) * 8.81 (2.17) * 4.11 (1.14) *
7. Co morbidity (yes) c
No 206 (73.8) 11.68 (2.59) 7.93 (2.22) 3.71 (0.85)
Yes 73 (26.2) 12.68 (2.37)* 8.81 (1.66) * 3.96 (1.01) #
8. Low back pain d
No 247 (88.5) 11.81 (2.55) 8.05 (2.12) 3.77 (0.93)
Yes 32 (11.5) 13.00 (2.46) # 9.00 (1.93) # 3.84 (0.88)
a Mixed but dominant stress UI.
b Surgical procedures were related to women's stress urinary incontinence.
c Co morbidity included (n): COPD (31), cardiovascular problems (25), and diabetes type-2 (15).
d (pseudo-) radicular symptoms included (n = 11).
* Significant difference between groups (p < 0.01).
# Significant difference between groups (p < 0.05)BMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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A potential weak point in the analyses could be that the
PRAFAB questionnaire item adjustment was skewed, thus
not normally distributed. Normality is not a necessary
assumption for PCA [13,19], but skewed distributions or
outliers could have distorted the results. However, the
results of our analyses do not support this potential dis-
tortion because the PCA results (e.g. the results of the
exploratory factor analysis as well as the results of the
'simple structure' confirmatory factor analysis) were fairly
identical and consistent in both study samples, though it
might be the reason for the lower and borderline factor
loading of the skewed item 'adjustment' as shown by the
maximum likelihood analysis. This study confirms the
hypothesized and proposed two-factorial structure of the
PRAFAB questionnaire using a cross validation study
design.
The consequence of the two-factor dimensionality is that
this measure is able to make a distinction between differ-
ent kinds of baseline severity and consequently different
kinds of outcomes: 'leakage severity' and 'perceived symp-
tom impact' of stress UI on the patient's life. The correla-
tion between these two scale scores was moderate (r =
0.31) indicating that the scale scores are measuring dis-
tinct but related dimensions of the PRAFAB questionnaire
and should be used as separate outcomes in future
research. The moderate correlation among the subscales is
in accordance with what we know from the literature. The
perceived symptom impact or consequence of stress UI
will be different from patient to patient and not necessar-
ily related to the severity of the stress UI leakage symp-
toms [2,4,5].
While it is not possible to measure in detail all potential
domains of the severity and perceived symptom impact of
stress UI, the brief, quick and easy to administer PRAFAB
questionnaire covers important aspects of stress UI, with
hardly any burden for the practitioners or the patient,
leading us to recommend its use in daily clinical practice.
However, we believe that in clinical practice it is still
worthwhile examining the individual PRAFAB question-
naire items for a better understanding of stress UI leakage
severity, perceived symptom impact, goals and type of
physiotherapy or other interventions for individual
patients.
Looking at the PRAFAB questionnaire in more detail from
the biopsychosocial perspective, the PRAFAB question-
naire could have potentially more than two meaningful
factors. For example, the amount and frequency items
might represent biological (impairment) factors, the body
(or self) image item the 'psychological' factor of bother
and the item adjustment (participation restrictions) the
'social' factor. In other words this instrument might also
fit the biopsychosocial approach. From our point of view
the item 'protection' was not assumed to be included in
the UI leakage severity subscale (Factor 1) but, although
strongly related to the amount and frequency of urine
loss, we considered 'protection' as a consequence or antic-
ipation of a likely event of urine loss. Despite that, the sin-
gle item 'protection' is informative and interesting from
the perspective of self-confidence for individual women
or from the perspective of cost to society. For example, the
costs of incontinence absorbent materials in the Nether-
lands were estimated at 119.3 million euro in 2004 [1,2].
Despite the impact of UI on quality of life and cost to soci-
ety only a minority who had consulted their GP were
receiving treatment, though some could have benefited
from an effective intervention [1,2]. Figures in the Nether-
lands showed that of all women who had consulted their
GP only 1.9% had been referred to urogynaecologists and
1.6% to specialized (and registered) physiotherapists in
women's health [2]. GPs and other (primary) care profes-
sionals need to be more alert in early identification and
referral of incontinent patients, offering tailored interven-
tions as recently stated in Dutch clinical urinary inconti-
nence guidelines as a vehicle for integrated (primary
health) care [27].
The patterns of the PRAFAB questionnaire scores in rela-
tion to the baseline characteristics also support the con-
struct validity of the PRAFAB questionnaire scores in this
study and are consistent with our expectations as demon-
strated in our previous psychometric study [7] and for
example by Fultz et al. [4] and Melville et al. [6]. As
expected, the total PRAFAB questionnaire scores and uri-
nary leakage severity scores were higher for patients
referred by urogynaecologists compared with those
referred by GPs, for patients with a self-rated lower physi-
cal health, failed UI-related surgery, co-morbid conditions
and chronic low back pain. Patients with a higher educa-
tion (compared to those who had not) had lower leakage
severity and perceived symptom impact scores. These con-
firmative findings underscore the validity of the PRAFAB
questionnaire. Furthermore it shows that patients with
higher scores on the subscale 'leakage severity' often per-
ceived a stronger impact of UI but this seems to be more
variable.
Temporary or permanent stress UI symptoms affect activ-
ities in daily life and may have a firm psychosocial impact
[2,4-6] that also needs to be addressed by the health pro-
fessionals involved. Brief, valid and responsive outcome
measures that can be used easily in clinical practice are
therefore highly recommended. For example, other and
competing outcome measures such as the Incontinence
Consultation on Incontinence Questionnaire (ICIQ) [28]
or the Incontinence Severity Index (ISI) [29,30], which
also demonstrate the face-validity of the PRAFAB ques-
tionnaire based on comparable items. However, the ISIBMC Urology 2008, 8:1 http://www.biomedcentral.com/1471-2490/8/1
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only focuses on urinary leakage severity and not on the
perceived impact of UI. The availability of brief and sim-
ple outcome measures, which lessen the scoring burden
for practitioners, will probably enhance the implementa-
tion of these outcome measures in clinical practice and
will also enhance informed decision-making in open
communication with the patient.
Conclusion
In summary, the findings demonstrate high factorial
validity and construct validity of the PRAFAB question-
naire and subscales. The subscales should be used as sep-
arate outcomes in future research and clinical practice.
However, the generalization of the two-factor solution for
different types of UI, higher age groups or for example to
a male population is still unclear. Further studies should
examine whether the questionnaire is also valid in other
(sub) populations. Nevertheless the results are promising.
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